Usefulness of neutrophil-to-lymphocyte ratios to predict pathologic response and prognosis in patients with operable breast cancer receiving neoadjuvant chemotherapy with nab-paclitaxel

被引：0
|
作者：
Yugo, N. [1 ]
Mizuno, Y. [1 ]
机构：
[1] Yokkaichi Municipal Hosp, Breast Surg Dept, Yokaichi, Japan
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.10.042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
22P
引用
收藏
页码：S1412 / S1412
页数：1
相关论文
共 50 条
  • [31] Is the Neutrophil-to-Lymphocyte Ratio a Predictive Factor of Pathological Complete Response in Egyptian Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?
    Ebaid, Naglaa F.
    Abdelkawy, Khaled S.
    Said, Amira S. A.
    Al-Ahmad, Mohamad M.
    Shehata, Mohamed A.
    Salem, Heba F.
    Hussein, Raghda R. S.
    MEDICINA-LITHUANIA, 2025, 61 (02):
  • [32] The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer
    Vernieri, Claudio
    Mennitto, Alessia
    Prisciandaro, Michele
    Huber, Veronica
    Milano, Monica
    Rinaldi, Lucia
    Cona, Maria Silvia
    Maggi, Claudia
    Ferrari, Benvenuto
    Manoukian, Siranoush
    Mariani, Gabriella
    Bianchi, Giulia
    Capri, Giuseppe
    Rivoltini, Licia
    de Braud, Filippo
    SCIENTIFIC REPORTS, 2018, 8
  • [33] The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer
    Claudio Vernieri
    Alessia Mennitto
    Michele Prisciandaro
    Veronica Huber
    Monica Milano
    Lucia Rinaldi
    Maria Silvia Cona
    Claudia Maggi
    Benvenuto Ferrari
    Siranoush Manoukian
    Gabriella Mariani
    Giulia Bianchi
    Giuseppe Capri
    Licia Rivoltini
    Filippo de Braud
    Scientific Reports, 8
  • [34] Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
    Liontos, M.
    Andrikopoulou, A.
    Koutsoukos, K.
    Markellos, C.
    Skafida, E.
    Fiste, O.
    Kaparelou, M.
    Thomakos, N.
    Haidopoulos, D.
    Rodolakis, A.
    Dimopoulos, M. A.
    Zagouri, F.
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [35] Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
    M. Liontos
    A. Andrikopoulou
    K. Koutsoukos
    C. Markellos
    E. Skafida
    O. Fiste
    M. Kaparelou
    N. Thomakos
    D. Haidopoulos
    A. Rodolakis
    M. A. Dimopoulos
    F. Zagouri
    Journal of Ovarian Research, 14
  • [36] Prognostic value of blood neutrophil-to-lymphocyte ratio (NLR) in advanced pancreatic cancer patients treated with Nab-paclitaxel and Gemcitabine: our experience
    Savastano, B.
    Ventriglia, J.
    Laterza, M. M.
    Petrillo, A.
    Tirino, G.
    Diana, A.
    Fabozzi, A.
    Giordano, G.
    Orditura, M.
    Ciardiello, F.
    De Vita, F.
    ANNALS OF ONCOLOGY, 2015, 26 : 102 - 102
  • [37] Neutrophil-to-Lymphocyte Ratio Dynamics and Pathologic Response Following Neoadjuvant Chemotherapy in Pancreatic Cancer: Clinical Evidence With Preclinical Modeling
    Silva, I. De Castro
    Sharma, P.
    Bianchi, A.
    Deshpande, N.
    Mehra, S.
    England, J.
    Kwon, D.
    Hosein, P.
    Merchant, N.
    Datta, J.
    PANCREAS, 2021, 50 (07) : 1053 - 1053
  • [38] Major pathologic response and biomarker predict survival in lung cancer patients receiving neoadjuvant chemotherapy
    Pataer, Apar
    Shao, Ruping
    Correa, Arlene M.
    Wistuba, Ignacio I.
    Swisher, Stephen G.
    CANCER RESEARCH, 2018, 78 (13)
  • [39] Does Neutrophil-to-Lymphocyte Ratio (NLR) Predict Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma?
    Anand, Santhosh
    Bhati, Gajendra
    Gurram, Ramprakash
    Gnanasekaran, Senthil
    Kate, Vikram
    Pottakkat, Biju
    Kalayarasan, Raja
    JOURNAL OF GASTROINTESTINAL CANCER, 2021, 52 (02) : 659 - 665
  • [40] Does Neutrophil-to-Lymphocyte Ratio (NLR) Predict Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma?
    Santhosh Anand
    Gajendra Bhati
    Ramprakash Gurram
    Senthil Gnanasekaran
    Vikram Kate
    Biju Pottakkat
    Raja Kalayarasan
    Journal of Gastrointestinal Cancer, 2021, 52 : 659 - 665
12345